Validation in both an external GEO dataset and in a mouse model showed that the hepatic mRNA expression of RPL35, RPS3A, and RPS8 was significantly decreased in NAFLD. This evidence concerns the gene RPL35 and metabolic dysfunction-associated steatotic liver disease.